Late Infections Seen With Rituxan in Vasculitis

LIVERPOOL--Treatment of vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA) with rituximab (Rituxan) is known to be effective, but in a U.K. cohort was associated with an increase in late-onset infections, a researcher reported here.
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news